- Issuer ticker
-
AVBP
- Reported as of
-
11 Jul 2025
- Net transaction value
-
+$25,429
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
15 Jul 2025, 07:00:15 UTC
Reporting owner
1 detail
- Reporting owner signature
-
By: /s/ James Kastenmayer, Attorney-in-Fact for Robin LaChapelle
Filing notes and source
Key filing fact
Robin LaChapelle filed Form 4 for ArriVent BioPharma, Inc. (AVBP) on 15 Jul 2025.
Key facts
- This page summarizes Robin LaChapelle's Form 4 filing for ArriVent BioPharma, Inc. (AVBP).
- 6 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 15 Jul 2025, 07:00.
Change
- Previous filing in this sequence was filed on 14 Feb 2025.
- Current net transaction value: +$25,429.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0002009136
Primary reporting owner
LaChapelle Robin
- Relationship
-
Chief Operating Officer
- Address
- C/O ARRIVENT BIOPHARMA, INC., 18 CAMPUS BOULEVARD, SUITE 100, NEWTOWN SQUARE
- Signature
- By: /s/ James Kastenmayer, Attorney-in-Fact for Robin LaChapelle
- Signature date
- 15 Jul 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AVBP
transaction
Common Stock
Options Exercise
- Transaction value
- $4,674
- Shares
- +2,050
- Change %
- +1.6%
- Price
-
$2.28
- Shares after
- 126,633
- Date
- 11 Jul 2025
- Ownership
- Direct
AVBP
transaction
Common Stock
Options Exercise
- Transaction value
- $5,928
- Shares
- +2,600
- Change %
- +2.1%
- Price
-
$2.28
- Shares after
- 129,233
- Date
- 11 Jul 2025
- Ownership
- Direct
AVBP
transaction
Common Stock
Options Exercise
- Transaction value
- $14,827
- Shares
- +6,503
- Change %
- +5%
- Price
-
$2.28
- Shares after
- 135,736
- Date
- 11 Jul 2025
- Ownership
- Direct
AVBP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 394,477
- Date
- 11 Jul 2025
- Ownership
- Held by The MAKS Yao Trust
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AVBP
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,050
- Change %
- -83%
- Price
-
$0.000000
- Shares after
- 410
- Date
- 11 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,050
- Exercise price
- $2.28
- Footnotes
- F2
AVBP
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,600
- Change %
- -17%
- Price
-
$0.000000
- Shares after
- 12,873
- Date
- 11 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,600
- Exercise price
- $2.28
- Footnotes
- F3
AVBP
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -6,503
- Change %
- -51%
- Price
-
$0.000000
- Shares after
- 6,370
- Date
- 11 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,503
- Exercise price
- $2.28
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Explanation of responses
3 footnotes